Canopy Growth Corp (CGC) stock
CGCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends March 31
$0.53−0.01 (-2.67%)
Close on Nov 17, 2026Market cap $224.80MP/E –Yield –
Canopy Growth cash
Cash and short-term investments held at the end of each period.
Canopy Growth's cash was C$336.63M at Jun 30, 2026. For fiscal 2026 it was C$364.68M, up 177.4% from the year before. Over ten years it grew 37.2% a year on average. The highest annual figure on record is C$4.51B in fiscal 2019.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | C$364.68M | +177.4% |
| FY2025 | Mar 31, 2025 | C$131.47M | -35.4% |
| FY2024 | Mar 31, 2024 | C$203.46M | -73.7% |
| FY2023 | Mar 31, 2023 | C$773.22M | -43.6% |
| FY2022 | Mar 31, 2022 | C$1.37B | -40.3% |
| FY2021 | Mar 31, 2021 | C$2.30B | +16.3% |
| FY2020 | Mar 31, 2020 | C$1.98B | -56.2% |
| FY2019 | Mar 31, 2019 | C$4.51B | +1299.7% |
| FY2018 | Mar 31, 2018 | C$322.56M | +216.9% |
| FY2017 | Mar 31, 2017 | C$101.80M | +561.2% |
| FY2016 | Mar 31, 2016 | C$15.40M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | C$336.63M | +134.4% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | C$364.68M | +177.4% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | C$371.32M | +108.2% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | C$298.06M | +28.9% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | C$143.63M | -26.3% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | C$131.47M | -35.4% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | C$178.34M | -4.2% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | C$231.22M | -14.5% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | C$194.92M | -65.9% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | C$203.46M | -73.7% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | C$186.18M | -76.4% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | C$270.38M | -76.4% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | C$571.07M | -53.1% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | C$773.22M | -43.6% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | C$789.25M | -44.5% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | C$1.14B | -41.6% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | C$1.22B | -40.7% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | C$1.37B | -40.3% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | C$1.42B | -10.7% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | C$1.96B | +13.7% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | C$2.05B | +0.7% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | C$2.30B | +16.3% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | C$1.59B | -64.7% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | C$1.72B | +433.9% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | C$2.04B | +1900.8% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | C$1.98B | +12736.9% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | C$4.51B | – |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | C$322.56M | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | C$101.80M | – |
| Q4 FY2016CQ1 2016 | Mar 31, 2016 | C$15.40M | – |
See a number that looks wrong?